COVID-19 studies for: C19 studies:  HC QHC Q IvermectinIVM Vitamin DVitamin D ZincZn REGN-COV2REGN LY-CoVLY RemdesivirRMD
HC Q study #163
Source   PDF   Share   Tweet
See all 181 studies
11/3
Positive
Pre-Exposure Prophylaxis study (treated before exposed to the virus)
Behera et al., medRxiv, doi:10.1101/2020.10.29.20222661v1 (Preprint)
Role of ivermectin in the prevention of COVID-19 infection among healthcare workers in India: A matched case-control study
Retrospective prophylaxis study for HC Q, ivermectin, and vitamin C with 372 healthcare workers, showing lower COVID-19 incidence for all treatments, with statistical significance reached for ivermectin.
HC Q OR 0.56, p = 0.29
Ivermectin OR 0.27, p < 0.001
Vitamin C OR 0.82, p = 0.58
COVID-19 case, ↓27.9%, p=0.29
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 181 studies
Please send us corrections, updates, or comments.
Submit